Duchenne Muscular Dystrophy Fatigue Trajectories
Neuropediatrics · 01.02.2024 · 55 (01) · 042-048
DOI: 10.1055/a-2101-7860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.02.2024. Verfasst von Yi Sally Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital London Health Sciences Centre, London, Canada. Hauptthemen laut MEDLINE: Quality of Life, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: PTC Therapeutics.
Abstract (Originalsprache)
Introduction
Children with Duchenne muscular dystrophy (DMD) are at risk of experiencing fatigue that negatively impacts their health-related quality of life (HRQoL). This study aimed to assess the association between fatigue and HRQoL, by examining fatigue trajectories over 48 weeks, and assessing factors associated with these fatigue trajectories.
Methods
The study sample consisted of 173 DMD subjects enrolled in a 48-week-long phase 2 clinical trial (NCT00592553) for a novel therapeutic who were between the ages of 5 and 16 years.
Results
The results of regression modeling show baseline fatigue and baseline HRQoL (R 2 = 0. 54 for child self-report and 0.51 for parent proxy report) and change in fatigue and HRQoL over 48 weeks (R 2 = 0.47 for child self-report and 0.36 for parent proxy report) were significantly associated with one another. Three unique fatigue trajectories using Latent Class Growth Models were identified for child and parent proxy reported fatigue. The risk of being in the high fatigue group as compared to the low fatigue group increased by 24% with each year increase in age and also with decreasing walking distance, as reported by children and parent proxy, respectively.
Conclusion
This study identified fatigue trajectories and risk factors associated with greater fatigue, helping clinicians and researchers identify the profile of fatigue in DMD children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Children's Hospital London Health Sciences Centre, London, Canada.
- Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
- Department of Paediatrics, Clinical Neurological Sciences and Epidemiology, Western University, London, Ontario, Canada.
Förderung
- PTC Therapeutics
Zitieren
APA
Wei, Y. S., Hnaini, M., ElAloul, B., Zapata, E., & Campbell, C. (2024). Duchenne Muscular Dystrophy Fatigue Trajectories. Neuropediatrics, 55(01), 042-048. https://doi.org/10.1055/a-2101-7860
Vancouver
Wei YS, Hnaini M, ElAloul B, Zapata E, Campbell C. Duchenne Muscular Dystrophy Fatigue Trajectories. Neuropediatrics. 2024;55(01):042-048. doi:10.1055/a-2101-7860
BibTeX
@article{Wei2024,
author = {Wei, Yi Sally and Hnaini, Mona and ElAloul, Basmah and Zapata, Eugenio and Campbell, Craig},
title = {Duchenne Muscular Dystrophy Fatigue Trajectories},
journal = {Neuropediatrics},
year = {2024},
volume = {55},
number = {01},
pages = {042--048},
doi = {10.1055/a-2101-7860}
}
EUVIMED